PF-Atlas › Clinical Trials › NCT03344861

Safety of PDT-Photofrin® Prior to Lung Surgery

Porfimer Sodium · Phase 1

Registry ID
NCT03344861
Phase
Phase 1
Status
Completed
Drug / intervention
Porfimer Sodium
Sponsor
Concordia Laboratories Inc.
Start
2017-08-14
Enrollment
10
Locations
8

About this trial

This research study is being conducted to assess the safety of PDT in subjects with peripherally located malignant tumors in lung parenchyma prior to surgical resection. It will involve up to 10 sites in USA. Participation will last 4 months.

View NCT03344861 on ClinicalTrials.gov →

Explore related

All Porfimer Sodium trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT03344861 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.